The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.
Primary Objectives: • To determine the feasibility of implementing a chatbot-facilitated remote informed consent (IC) process. Secondary Objectives * To identify determinants of patient acceptance and usage of the chatbot. * To determine the accuracy and completeness of information delivered via the chatbot. * To determine the quality of the chatbot-facilitated remote IC process. * To determine the feasibility of using the chatbot for patient eligibility verification.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
100
A patient-facing chatbot designed to obtain informed consent
UT MD Anderson
Houston, Texas, United States
Safety and Adverse Events (AEs)
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Time frame: Through study completion; an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.